Come up with a name for your new list and we'll add to it:
Salient Pharmaceuticals raised a round of funding on January 06, 2010. Investors include
Texas Emerging Technology Fund.
Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…